about
Role of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and ThrombosisBioassay-Guided Isolation and HPLC Determination of Bioactive Compound That Relate to the Antiplatelet Activity (Adhesion, Secretion, and Aggregation) from Solanum lycopersicum.Prevalence of antiphospholipid and antiplatelet antibodies in human immunodeficiency virus (HIV)-infected Chilean patients.Prevalence of heparin-induced antibodies in patients with chronic renal failure undergoing hemodialysis.Prevalence of antiphospholipid antibodies in Chilean patients with rheumatoid arthritis.Thrombus formation induced by laser in a mouse modelInhibition of platelet activation and thrombus formation by adenosine and inosine: studies on their relative contribution and molecular modelingA novel role of Eruca sativa Mill. (rocket) extract: antiplatelet (NF-κB inhibition) and antithrombotic activities.The influence of ethnicity on warfarin dosage requirements in the chilean population.Chlorogenic acid inhibits human platelet activation and thrombus formation.Adenosine A2A receptor agonists with potent antiplatelet activity.Antioxidant and Antiplatelet Activities in Extracts from Green and Fully Ripe Tomato Fruits (Solanum lycopersicum) and Pomace from Industrial Tomato Processing.An insight into the pathophysiology of thrombosis in antiphospholipid syndrome.Mechanisms of chronic state of inflammation as mediators that link obese adipose tissue and metabolic syndromeProtective Mechanisms of S. lycopersicum Aqueous Fraction (Nucleosides and Flavonoids) on Platelet Activation and Thrombus Formation: In Vitro, Ex Vivo and In Vivo StudiesMauritia flexuosa Presents In Vitro and In Vivo Antiplatelet and Antithrombotic Activities.Effect of tomato industrial processing (different hybrids, paste, and pomace) on inhibition of platelet function in vitro, ex vivo, and in vivo.Gene expression of adipose tissue, endothelial cells and platelets in subjects with metabolic syndrome (Review).Role of PPARs in inflammatory processes associated with metabolic syndrome (Review).Mechanism of the anti-platelet effect of natural bioactive compounds: role of peroxisome proliferator-activated receptors activation.Role of multiligand/RAGE axis in platelet activation.Relationship between Platelet PPARs, cAMP Levels, and P-Selectin Expression: Antiplatelet Activity of Natural Products.Regulatory mechanisms of cAMP levels as a multiple target for antiplatelet activity and less bleeding risk.Mechanism of antiplatelet action of hypolipidemic, antidiabetic and antihypertensive drugs by PPAR activation: PPAR agonists: new antiplatelet agents.Mechanisms of endothelial cell protection by hydroxycinnamic acids.Extracellular ATP metabolism on vascular endothelial cells: A pathway with pro-thrombotic and anti-thrombotic molecules.Platelet miRNAs and cardiovascular diseases.Primary and secondary haemostasis changes related to aging.Cross-talk between platelet and tumor microenvironment: Role of multiligand/RAGE axis in platelet activation.Role of oxidative stress on platelet hyperreactivity during aging.NF-κB signaling pathway as target for antiplatelet activity.Role of adenosine A2b receptor overexpression in tumor progression.Antiplatelet activity of drugs used in hypertension, dyslipidemia and diabetes: Additional benefit in cardiovascular diseases prevention.Mechanisms of endothelial dysfunction during aging: Predisposition to thrombosis.Platelet oxidative stress as a novel target of cardiovascular risk in frail older people.Role of access to parks and markets with anthropometric measurements, biological markers, and a healthy lifestyle.Immune System Dysfunction in the Elderly.Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.).Intervention with education and exercise reverses the metabolic syndrome in adults.PAMAM dendrimer derivatives as a potential drug for antithrombotic therapy.
P50
Q28069254-B5CD58F8-9D8D-4B49-82ED-7F48DB7F607DQ30528868-DF6E74C0-A556-44DB-BB82-24F33624D1F3Q33357573-8FD8EF4E-4569-4E4C-AF91-1A64D0267867Q33368523-55681CEE-3601-47D6-83DE-20EBF2F49950Q33372577-28894284-A875-4960-9049-5918A931E9AAQ33769530-9719C71F-3AFF-4B9B-919C-B2F0D10B3DA6Q34506411-08B525DE-ACBE-470C-B012-46DCF85BFA2FQ34775072-AD7E729E-3B63-4FFF-8984-63621A3B6015Q35086264-7BA0FCDC-501D-42BD-8CC7-1B6C882560C8Q35112024-10C6342B-88DC-4B9C-AA0C-80661CDC2AE8Q36371663-77F777EA-3118-45B4-A978-D8D5368FB7D9Q36656586-F55888B8-31CD-40DA-AB2A-46FEEA040505Q36813675-25A738D7-A595-42B0-BEA3-F079A6B60F4AQ36970120-F23E4E91-44E1-4E0A-A6B7-8B617128AF17Q37212771-8468D194-321E-4A4D-8BC4-B2BB165C1D31Q37427120-F09F4DC4-10EA-4259-A4BC-F5A14EF87C7AQ37712690-D4EDCB62-04E4-41FD-985A-9A9293A04C91Q37983393-1C74833F-4BF2-4BDF-94A2-E154D7945321Q38150172-1DF8480D-A00C-4457-9670-EE6C2A51EE62Q38163612-2AF1E270-7705-4DF1-8DF8-5DF0436C2B03Q38167989-3EB51212-609F-40C1-B2FF-01C79D1D974BQ38170115-0209A4F8-9FF9-4AC9-8528-11A25790DC33Q38211932-FB1C55B3-A09D-44AE-8E4B-ED54264F2CEDQ38215838-DBBCFB97-6E52-4FDB-A4B6-2AF48D7C9B8FQ38280393-12019F27-A16F-4E11-A1A8-2D68A6018625Q38491295-D24DDA01-54A3-4717-90A6-7CD1A3F902A8Q38499853-FB0677F3-3D26-4806-8BF3-32C2BF73E9FAQ38571248-DEBD8D9A-521B-49BB-9D95-8C0485B5A767Q38684969-D4FDDE08-A0B1-475C-846A-C35F3C21A6E4Q38731638-69CC0317-EDC5-4D81-8D05-EF4C77457ACBQ38807640-46F6D268-8384-4B0A-AFBD-1BDB2C5C08E4Q38978207-C1B5E2D2-8327-4851-A349-A327C3E7A613Q39200522-6F181197-CC5A-475A-9D34-29C3BDB2E7CAQ39288136-D8A95A6A-E6A4-4CCC-ADFC-98936C027F7EQ39433616-DDC42725-F297-4702-8393-B2C2A50540EEQ40223233-706A0747-BF3F-456C-B09D-A5B720645716Q40245420-9D0386D0-3AA7-4268-84E1-890C11C86062Q42324464-DE20BC5C-7571-46AD-B6A3-BA59F1E58553Q43062934-E49F3EC9-D43C-49A8-981E-CD5488A36F34Q43626870-152A7371-3EEE-49D0-BAAE-2A30D5F012B7
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Iván Palomo
@ast
Iván Palomo
@en
Iván Palomo
@es
Iván Palomo
@nl
Iván Palomo
@sl
type
label
Iván Palomo
@ast
Iván Palomo
@en
Iván Palomo
@es
Iván Palomo
@nl
Iván Palomo
@sl
prefLabel
Iván Palomo
@ast
Iván Palomo
@en
Iván Palomo
@es
Iván Palomo
@nl
Iván Palomo
@sl
P108
P106
P1153
15830080800
P21
P31
P496
0000-0002-9618-8778